Monitoring patients receiving monoclonal antibodies (part 1)
Type de matériel :
TexteLangue : français Détails de publication : 2023.
Sujet(s) : Ressources en ligne : Abrégé : The growing interest in biomedicine—particularly in the form of monoclonal antibodies—in cancerology, but also in inflammatory, infectious, and autoimmune diseases, means that GPs today need to be in a position to support these patients. What questions should they be able to answer, and how should they carry out monitoring? This first part deals with general information, vaccination, and travel, while the second part looks at monitoring and the main adverse effects.
Nous n'avons pas d'exemplaire de ce document
58
The growing interest in biomedicine—particularly in the form of monoclonal antibodies—in cancerology, but also in inflammatory, infectious, and autoimmune diseases, means that GPs today need to be in a position to support these patients. What questions should they be able to answer, and how should they carry out monitoring? This first part deals with general information, vaccination, and travel, while the second part looks at monitoring and the main adverse effects.
Réseaux sociaux